Raichle ME, Gusnard DA. Appraising the brain’s energy budget. Proc Natl Acad Sci USA. 2002;99(16):10237–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Muoio V, Persson PB, Sendeski MM. The neurovascular unit—concept review. Acta Physiol. 2014;210(4):790–8.
Article
CAS
Google Scholar
Kreczmanski P, et al. Microvessel length density, total length, and length per neuron in five subcortical regions in schizophrenia. Acta Neuropathol. 2009;117(4):409–21.
Article
PubMed
Google Scholar
Gross PM, et al. Differences in function and structure of the capillary endothelium in gray matter, white matter and a circumventricular organ of rat brain. Blood Vessels. 1986;23(6):261–70.
CAS
PubMed
Google Scholar
Sweeney MD, et al. Blood–Brain barrier: from physiology to disease and back. Physiol Rev. 2019;99(1):21–78.
Article
PubMed
Google Scholar
Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci. 2006;7(1):41–53.
Article
CAS
PubMed
Google Scholar
Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood–brain barrier. Nat Med. 2013;19(12):1584–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844–66.
Article
CAS
PubMed
Google Scholar
Morita K, et al. Endothelial claudin: claudin-5/Tmvcf constitutes tight junction strands in endothelial cells. J Cell Biol. 1999;147(1):185–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology. 2001;120(2):411–22.
Article
CAS
PubMed
Google Scholar
Reyes JL, et al. The renal segmental distribution of claudins changes with development. Kidney Int. 2002;62(2):476–87.
Article
CAS
PubMed
Google Scholar
Morita K, et al. Expression of claudin-5 in dermal vascular endothelia. Exp Dermatol. 2003;12(3):289–95.
Article
CAS
PubMed
Google Scholar
Kojima S, et al. Claudin 5 is transiently expressed during the development of the retinal pigment epithelium. J Membr Biol. 2002;186(2):81–8.
Article
CAS
PubMed
Google Scholar
Louveau A, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baluk P, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204(10):2349–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Daneman R, et al. The mouse blood–brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE. 2010;5(10):e13741.
Article
PubMed
PubMed Central
CAS
Google Scholar
Collins MM, Baumholtz AI, Ryan AK. Claudin-5 expression in the vasculature of the developing chick embryo. Gene Expr Patterns. 2012;12(3–4):123–9.
Article
CAS
PubMed
Google Scholar
Daneman R, et al. Pericytes are required for blood–brain barrier integrity during embryogenesis. Nature. 2010;468(7323):562–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Virgintino D, et al. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem Cell Biol. 2004;122(1):51–9.
Article
CAS
PubMed
Google Scholar
Alvarez JI, et al. The Hedgehog pathway promotes blood–brain barrier integrity and CNS immune quiescence. Science. 2011;334(6063):1727–31.
Article
CAS
PubMed
Google Scholar
Armulik A, et al. Pericytes regulate the blood–brain barrier. Nature. 2010;468(7323):557–61.
Article
CAS
PubMed
Google Scholar
Bell RD, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010;68(3):409–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hellstrom M, et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999;126(14):3047–55.
CAS
PubMed
Google Scholar
Chen J, et al. CD146 coordinates brain endothelial cell-pericyte communication for blood–brain barrier development. Proc Natl Acad Sci USA. 2017;114:E7622–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Daneman R, et al. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci USA. 2009;106(2):641–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Paul D, et al. Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels. Microvasc Res. 2013;86:1–10.
Article
CAS
PubMed
Google Scholar
Ohtsuki S, et al. mRNA expression levels of tight junction protein genes in mouse brain capillary endothelial cells highly purified by magnetic cell sorting. J Neurochem. 2008;104(1):147–54.
CAS
PubMed
Google Scholar
Suzuki H, et al. Crystal structure of a claudin provides insight into the architecture of tight junctions. Science. 2014;344(6181):304–7.
Article
CAS
PubMed
Google Scholar
Nitta T, et al. Size-selective loosening of the blood–brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161(3):653–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Greene C, et al. Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. Mol Psychiatry. 2017;23(11):2156–66.
Article
PubMed
PubMed Central
CAS
Google Scholar
Menard C, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20(12):1752–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matsumoto-Okazaki Y, Furuse M, Kajiya K. Claudin-5 haploinsufficiency exacerbates UVB-induced oedema formation by inducing lymphatic vessel leakage. Exp Dermatol. 2012;21(7):557–9.
Article
CAS
PubMed
Google Scholar
Swager SA, et al. Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1. Cardiovasc Pathol. 2015;24(3):160–7.
Article
CAS
PubMed
Google Scholar
Delfín DA, et al. Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model. Mol Ther. 2012;20(7):1378–83.
Article
PubMed
PubMed Central
CAS
Google Scholar
Morrow CM, et al. Claudin 5 expression in mouse seminiferous epithelium is dependent upon the transcription factor ets variant 5 and contributes to blood-testis barrier function. Biol Reprod. 2009;81(5):871–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Turunen M, et al. Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma. Anticancer Res. 2009;29(12):5185–9.
CAS
PubMed
Google Scholar
Coutinho-Camillo CM, et al. Claudin expression is dysregulated in prostate adenocarcinomas but does not correlate with main clinicopathological parameters. Pathology. 2011;43(2):143–8.
Article
CAS
PubMed
Google Scholar
Wen H, et al. Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5. Mol Cell Biol. 2004;24(19):8408–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Piontek J, et al. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 2008;22(1):146–58.
Article
CAS
PubMed
Google Scholar
Rossa J, et al. Claudin-3 and claudin-5 protein folding and assembly into the tight junction are controlled by non-conserved residues in the transmembrane 3 (TM3) and extracellular loop 2 (ECL2) segments. J Biol Chem. 2014;289(11):7641–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gehne N, et al. Cross-over endocytosis of claudins is mediated by interactions via their extracellular loops. PLoS ONE. 2017;12(8):e0182106.
Article
PubMed
PubMed Central
CAS
Google Scholar
Blasig IE, et al. On the self-association potential of transmembrane tight junction proteins. Cell Mol Life Sci. 2006;63(4):505–14.
Article
CAS
PubMed
Google Scholar
Furuse M, Sasaki H, Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol. 1999;147(4):891–903.
Article
CAS
PubMed
PubMed Central
Google Scholar
Krause G, et al. Structure and function of claudins. Biochim Biophys Acta. 2008;1778(3):631–45.
Article
CAS
PubMed
Google Scholar
Krause G, et al. Structure and function of extracellular claudin domains. Ann N Y Acad Sci. 2009;1165:34–43.
Article
CAS
PubMed
Google Scholar
Osada T, et al. Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by β(1)-integrins. J Cereb Blood Flow Metab. 2011;31(10):1972–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Itoh M, et al. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol. 1999;147(6):1351–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Luissint A-C, et al. Guanine nucleotide-binding protein Gαi2: a new partner of claudin-5 that regulates tight junction integrity in human brain endothelial cells. J Cereb Blood Flow Metab. 2012;32(5):860–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ruffer C, Gerke V. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions. Eur J Cell Biol. 2004;83(4):135–44.
Article
PubMed
Google Scholar
Liao Z, et al. Specific binding of a mutated fragment of Clostridium perfringens enterotoxin to endothelial claudin-5 and its modulation of cerebral vascular permeability. Neuroscience. 2016;327:53–63.
Article
CAS
PubMed
Google Scholar
Abbott NJ, et al. Structure and function of the blood–brain barrier. Neurobiol Dis. 2010;37(1):13–25.
Article
CAS
PubMed
Google Scholar
Butt AM, Jones HC, Abbott NJ. Electrical resistance across the blood–brain barrier in anaesthetized rats: a developmental study. J Physiol. 1990;429:47–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wolburg H, Lippoldt A. Tight junctions of the blood–brain barrier: development, composition and regulation. Vasc Pharmacol. 2002;38(6):323–37.
Article
CAS
Google Scholar
Bauer HC, et al. Neovascularization and the appearance of morphological characteristics of the blood–brain barrier in the embryonic mouse central nervous system. Brain Res Dev Brain Res. 1993;75(2):269–78.
Article
CAS
PubMed
Google Scholar
Amasheh S, et al. Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res. 2005;321(1):89–96.
Article
CAS
PubMed
Google Scholar
Ohtsuki S, et al. Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells. J Cell Physiol. 2007;210(1):81–6.
Article
CAS
PubMed
Google Scholar
Keaney J, et al. Autoregulated paracellular clearance of amyloid-beta across the blood–brain barrier. Sci Adv. 2015;1(8):e1500472.
Article
PubMed
PubMed Central
Google Scholar
Yamamoto M, et al. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am J Pathol. 2008;172(2):521–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Taddei A, et al. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol. 2008;10(8):923–34.
Article
CAS
PubMed
Google Scholar
Morini MF, et al. VE-cadherin-mediated epigenetic regulation of endothelial gene expression. Circ Res. 2018;122(2):231–45.
Article
CAS
PubMed
Google Scholar
Dalmasso AP, et al. Interleukin-4 induces up-regulation of endothelial cell claudin-5 through activation of FoxO1: role in protection from complement-mediated injury. J Biol Chem. 2014;289(2):838–47.
Article
CAS
PubMed
Google Scholar
Ishizaki T, et al. Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood–brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp Cell Res. 2003;290(2):275–88.
Article
CAS
PubMed
Google Scholar
Soma T, et al. Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Exp Cell Res. 2004;300(1):202–12.
Article
CAS
PubMed
Google Scholar
Camire RB, et al. Biphasic modulation of paracellular claudin-5 expression in mouse brain endothelial cells is mediated through the phosphoinositide-3-kinase/AKT pathway. J Pharmacol Exp Ther. 2014;351(3):654–62.
Article
PubMed
PubMed Central
CAS
Google Scholar
Persidsky Y, et al. Rho-mediated regulation of tight junctions during monocyte migration across the blood–brain barrier in HIV-1 encephalitis (HIVE). Blood. 2006;107(12):4770–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stamatovic SM, et al. Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem. 2006;281(13):8379–88.
Article
CAS
PubMed
Google Scholar
Willis CL, Meske DS, Davis TP. Protein kinase C activation modulates reversible increase in cortical blood–brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab. 2010;30(11):1847–59.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chiu P-S, Lai S-C. Matrix metalloproteinase-9 leads to claudin-5 degradation via the NF-κB pathway in BALB/c mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis. PLoS ONE. 2013;8(3):e53370.
Article
CAS
PubMed
PubMed Central
Google Scholar
Argaw AT, et al. VEGF-mediated disruption of endothelial CLN-5 promotes blood–brain barrier breakdown. Proc Natl Acad Sci USA. 2009;106(6):1977–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hudson N, et al. Differential apicobasal VEGF signaling at vascular blood-neural barriers. Dev Cell. 2014;30(5):541–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu X, et al. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors. Microvasc Res. 2006;71(1):12–9.
Article
CAS
PubMed
Google Scholar
Watabe T, et al. TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J Cell Biol. 2003;163(6):1303–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ota T, et al. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells. J Cell Physiol. 2002;193(3):299–318.
Article
CAS
PubMed
Google Scholar
Ronaldson PT, et al. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood–brain barrier during inflammatory pain. J Cereb Blood Flow Metab. 2009;29(6):1084–98.
Article
CAS
PubMed
Google Scholar
McMillin MA, et al. TGFβ1 exacerbates blood–brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5. Lab Invest. 2015;95(8):903–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shen W, et al. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-beta1-induced permeability of centrally derived vascular endothelium. Eur J Cell Biol. 2011;90(4):323–32.
Article
CAS
PubMed
Google Scholar
Shimizu F, et al. Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood–brain barrier and the blood-nerve barrier. Neurochem Res. 2012;37(2):401–9.
Article
CAS
PubMed
Google Scholar
Honda M, et al. Adrenomedullin improves the blood–brain barrier function through the expression of claudin-5. Cell Mol Neurobiol. 2006;26(2):109–18.
Article
CAS
PubMed
Google Scholar
Burek M, Forster CY. Cloning and characterization of the murine claudin-5 promoter. Mol Cell Endocrinol. 2009;298(1–2):19–24.
Article
CAS
PubMed
Google Scholar
Fontijn RD, et al. SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function. Am J Physiol Heart Circ Physiol. 2008;294(2):H891–900.
Article
CAS
PubMed
Google Scholar
Bhatwadekar AD, et al. Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow. Diabetes. 2013;62(1):273–82.
Article
CAS
PubMed
Google Scholar
Westgate EJ, et al. Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation. 2008;117(16):2087–95.
Article
PubMed
Google Scholar
Aslam M, et al. TNF-alpha induced NFkappaB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells. Cytokine. 2012;57(2):269–75.
Article
CAS
PubMed
Google Scholar
Aveleira CA, et al. TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes. 2010;59(11):2872–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Burek M, Steinberg K, Forster CY. Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor alpha and beta. Mol Cell Endocrinol. 2014;392(1–2):144–51.
Article
CAS
PubMed
Google Scholar
Sandoval KE, Witt KA. Age and 17beta-estradiol effects on blood–brain barrier tight junction and estrogen receptor proteins in ovariectomized rats. Microvasc Res. 2011;81(2):198–205.
Article
CAS
PubMed
Google Scholar
Burek M, et al. Claudin-5 as a novel estrogen target in vascular endothelium. Arterioscler Thromb Vasc Biol. 2010;30(2):298–304.
Article
CAS
PubMed
Google Scholar
Lu D, et al. Activation of G protein-coupled estrogen receptor 1 (GPER-1) ameliorates blood–brain barrier permeability after global cerebral ischemia in ovariectomized rats. Biochem Biophys Res Commun. 2016;477(2):209–14.
Article
CAS
PubMed
Google Scholar
Shin JA, et al. Activation of classical estrogen receptor subtypes reduces tight junction disruption of brain endothelial cells under ischemia/reperfusion injury. Free Radic Biol Med. 2016;92:78–89.
Article
CAS
PubMed
Google Scholar
Braniste V, et al. The gut microbiota influences blood–brain barrier permeability in mice. Sci Transl Med. 2014;6(263):263ra158.
Article
PubMed
PubMed Central
CAS
Google Scholar
Mandel I, et al. The ubiquitin-proteasome pathway regulates claudin 5 degradation. J Cell Biochem. 2012;113(7):2415–23.
Article
CAS
PubMed
Google Scholar
Liu J, et al. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood–brain barrier damage in early ischemic stroke stage. J Neurosci. 2012;32(9):3044–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stamatovic SM, et al. Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J Biol Chem. 2009;284(28):19053–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu J, et al. Nitric Oxide interacts with caveolin-1 to facilitate autophagy-lysosome-mediated claudin-5 degradation in oxygen-glucose deprivation-treated endothelial Cells. Mol Neurobiol. 2016;53(9):5935–47.
Article
CAS
PubMed
Google Scholar
Ramirez SH, et al. Inhibition of glycogen synthase kinase 3beta promotes tight junction stability in brain endothelial cells by half-life extension of occludin and claudin-5. PLoS ONE. 2013;8(2):e55972.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zlokovic BV. The blood–brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57(2):178–201.
Article
CAS
PubMed
Google Scholar
Lazear HM, et al. Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood–brain barrier. Sci Transl Med. 2015;7(284):284ra59.
Article
PubMed
PubMed Central
CAS
Google Scholar
Camire RB, Beaulac HJ, Willis CL. Transitory loss of glia and the subsequent modulation in inflammatory cytokines/chemokines regulate paracellular claudin-5 expression in endothelial cells. J Neuroimmunol. 2015;284:57–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314–8.
Article
CAS
PubMed
Google Scholar
Winger RC, et al. Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood–brain barrier. J Immunol. 2014;193(5):2427–37.
Article
CAS
PubMed
Google Scholar
Paul D, et al. Appearance of claudin-5(+) leukocytes in the central nervous system during neuroinflammation: a novel role for endothelial-derived extracellular vesicles. J Neuroinflamm. 2016;13(1):292.
Article
CAS
Google Scholar
Mandel I, et al. Tight junction proteins expression and modulation in immune cells and multiple sclerosis. J Cell Mol Med. 2012;16(4):765–75.
Article
PubMed
PubMed Central
Google Scholar
Singh VB, et al. Smoothened agonist reduces human immunodeficiency virus type-1-induced blood–brain barrier breakdown in humanized mice. Scientific reports. 2016;6:26876.
Article
CAS
PubMed
PubMed Central
Google Scholar
Roe K, et al. West Nile virus-induced disruption of the blood–brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virol. 2012;93(Pt 6):1193–203.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim BJ, et al. Bacterial induction of Snail1 contributes to blood–brain barrier disruption. J Clin Invest. 2015;125(6):2473–83.
Article
PubMed
PubMed Central
Google Scholar
Alvarez JI, Cayrol R, Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta. 2011;1812(2):252–64.
Article
CAS
PubMed
Google Scholar
Alvarez JI, et al. Focal disturbances in the blood–brain barrier are associated with formation of neuroinflammatory lesions. Neurobiol Dis. 2015;74:14–24.
Article
CAS
PubMed
Google Scholar
Bennett J, et al. Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J Neuroimmunol. 2010;229(1–2):180–91.
Article
CAS
PubMed
Google Scholar
Blecharz KG, et al. Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis. Mult Scler J. 2010;16(3):293–302.
Article
CAS
Google Scholar
Lutz SE, et al. Caveolin1 Is required for Th1 cell infiltration, but not tight junction remodeling, at the blood–brain barrier in autoimmune neuroinflammation. Cell Rep. 2017;21(8):2104–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Grygorowicz T, Dabrowska-Bouta B, Struzynska L. Administration of an antagonist of P2X7 receptor to EAE rats prevents a decrease of expression of claudin-5 in cerebral capillaries. Purinergic Signal. 2018;8:1–9.
Google Scholar
Ni C, et al. Interferon-gamma safeguards blood–brain barrier during experimental autoimmune encephalomyelitis. Am J Pathol. 2014;184(12):3308–20.
Article
CAS
PubMed
Google Scholar
Lanz TV, et al. Protein kinase Cβ as a therapeutic target stabilizing blood–brain barrier disruption in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2013;110(36):14735–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baskaya MK, et al. The biphasic opening of the blood–brain barrier in the cortex and hippocampus after traumatic brain injury in rats. Neurosci Lett. 1997;226(1):33–6.
Article
CAS
PubMed
Google Scholar
Koto T, et al. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol. 2007;170(4):1389–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang Y, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27(4):697–709.
Article
CAS
PubMed
Google Scholar
Knowland D, et al. Stepwise recruitment of transcellular and paracellular pathways underlies blood–brain barrier breakdown in stroke. Neuron. 2014;82(3):603–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nag S, Venugopalan R, Stewart DJ. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood–brain barrier breakdown. Acta Neuropathol. 2007;114(5):459–69.
Article
CAS
PubMed
Google Scholar
Campbell M, et al. Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury. Nat Commun. 2012;3:849.
Article
PubMed
CAS
Google Scholar
Doherty CP, et al. Blood–brain barrier dysfunction as a hallmark pathology in chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2016;75(7):656–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Farrell M, et al. Blood–brain barrier dysfunction in a boxer with chronic traumatic encephalopathy and schizophrenia. Clin Neuropathol. 2018. https://doi.org/10.5414/NP301130.
Article
PubMed
Google Scholar
Henshall DC, et al. MicroRNAs in epilepsy: pathophysiology and clinical utility. Lancet Neurol. 2016;15(13):1368–76.
Article
CAS
PubMed
Google Scholar
Friedman A. Blood–brain barrier dysfunction, status epilepticus, seizures and epilepsy: a puzzle of a chicken and egg? Epilepsia. 2011;52(Suppl 8):19–20.
Article
PubMed
PubMed Central
Google Scholar
van Vliet EA, et al. Blood–brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain. 2007;130(Pt 2):521–34.
Article
PubMed
Google Scholar
Marchi N, et al. Seizure-promoting effect of blood–brain barrier disruption. Epilepsia. 2007;48(4):732–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Seiffert E, et al. Lasting blood–brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci. 2004;24(36):7829–36.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yan BC, et al. Changes in the blood–brain barrier function are associated with hippocampal neuron death in a kainic acid mouse model of epilepsy. Frontiers in neurology. 2018;9:775.
Article
PubMed
PubMed Central
Google Scholar
Kim JY, et al. ETB receptor-mediated MMP-9 activation induces vasogenic edema via ZO-1 protein degradation following status epilepticus. Neuroscience. 2015;304:355–67.
Article
CAS
PubMed
Google Scholar
Liu JY, et al. Neuropathology of the blood–brain barrier and pharmaco-resistance in human epilepsy. Brain. 2012;135(Pt 10):3115–33.
Article
PubMed
Google Scholar
Rigau V, et al. Angiogenesis is associated with blood–brain barrier permeability in temporal lobe epilepsy. Brain. 2007;130(Pt 7):1942–56.
Article
PubMed
Google Scholar
Rempe RG, et al. Matrix metalloproteinase-mediated blood–brain barrier dysfunction in epilepsy. J Neurosci. 2018;38(18):4301–15.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kealy J, Greene C, Campbell M. Blood-brain barrier regulation in psychiatric disorders. Neurosci Lett. 2018. https://doi.org/10.1016/j.neulet.2018.06.033.
Article
PubMed
Google Scholar
Sun ZY, et al. The CLDN5 locus may be involved in the vulnerability to schizophrenia. Eur Psychiatry. 2004;19(6):354–7.
Article
PubMed
Google Scholar
Wu N, et al. A weak association of the CLDN5 locus with schizophrenia in Chinese case-control samples. Psychiatry Res. 2010;178(1):223.
Article
CAS
PubMed
Google Scholar
Ye L, et al. Further study of a genetic association between the CLDN5 locus and schizophrenia. Schizophr Res. 2005;75(1):139–41.
Article
PubMed
Google Scholar
Nishiura K, et al. PKA activation and endothelial claudin-5 breakdown in the schizophrenic prefrontal cortex. Oncotarget. 2017;8(55):93382–91.
PubMed
PubMed Central
Google Scholar
Schachtrup C, et al. Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor. Proc Natl Acad Sci USA. 2007;104(28):11814–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Santha P, et al. Restraint stress-induced morphological changes at the blood–brain barrier in adult rats. Front Mol Neurosci. 2015;8:88.
PubMed
Google Scholar
Lee S, et al. Real-time in vivo two-photon imaging study reveals decreased cerebro-vascular volume and increased blood–brain barrier permeability in chronically stressed mice. Sci Rep. 2018;8(1):13064.
Article
PubMed
PubMed Central
CAS
Google Scholar
Northrop NA, Yamamoto BK. Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood–brain barrier. J Neuroimmune Pharmacol. 2012;7(4):951–68.
Article
PubMed
PubMed Central
Google Scholar
Huber JD, et al. Inflammatory pain alters blood–brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol. 2001;280(3):H1241–8.
Article
CAS
PubMed
Google Scholar
Brooks TA, et al. Chronic inflammatory pain leads to increased blood–brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol. 2005;289(2):H738–43.
Article
CAS
PubMed
Google Scholar
Brooks TA, et al. Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res. 2006;1120(1):172–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Campos CR, et al. Nociceptive inhibition prevents inflammatory pain induced changes in the blood–brain barrier. Brain Res. 2008;1221:6–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yucel M, et al. Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci. 2016;20(5):930–6.
CAS
PubMed
Google Scholar
Cottier KE, et al. Loss of blood–brain barrier integrity in a KCl-induced model of episodic headache enhances CNS drug delivery. eNeuro. 2018. https://doi.org/10.1523/ENEURO.0116-18.2018.
Article
PubMed
PubMed Central
Google Scholar
Campbell M, et al. An experimental platform for systemic drug delivery to the retina. Proc Natl Acad Sci USA. 2009;106(42):17817–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Greene C, Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 2016;4(1):e1138017.
Article
PubMed
PubMed Central
CAS
Google Scholar
Dithmer S, et al. Claudin peptidomimetics modulate tissue barriers for enhanced drug delivery. Ann N Y Acad Sci. 2017;1397(1):169–84.
Article
CAS
PubMed
Google Scholar
Ishrat T, et al. Progesterone and allopregnanolone attenuate blood–brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp Neurol. 2010;226(1):183–90.
Article
CAS
PubMed
PubMed Central
Google Scholar